Agilent (NYSE: A) director Judy Brown granted 2,158 fully vested shares

Rhea-AI Filing Summary

Agilent Technologies director Judy L. Brown received a stock award of 2,158 shares of common stock on March 19, 2026. The award for non-employee directors is fully vested upon grant and was valued at $111.75 per share. Following this grant, Brown directly owns 3,835 Agilent shares. This is a compensation-related share acquisition rather than an open-market purchase.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Brown Judy L

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	2,158	$111.75	$241K

Holdings After Transaction: Common Stock — 3,835 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Brown Judy L

(Last) (First) (Middle)

5301 STEVENS CREEK BLVD.

(Street)

SANTA CLARA CALIFORNIA 95051

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AGILENT TECHNOLOGIES, INC. [ A ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/19/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/19/2026		A		2,158	A	$111.75(1)	3,835	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares acquired from award of Agilent Technologies, Inc. common stock for Non-Employee Directors that are fully vested upon grant.

Remarks:

See Exhibit 24 - Power of Attorney

	/s/ Shirley Qin, attorney-in-fact for Ms. Brown	03/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Agilent (A) director Judy L. Brown report in this Form 4?

Judy L. Brown reported receiving an award of 2,158 shares of Agilent common stock. The grant was made as non-employee director compensation and is fully vested upon grant, increasing her direct holdings to 3,835 shares following the transaction.

Was the Agilent (A) Form 4 transaction a market purchase or a stock award?

The Form 4 shows a stock award, not a market purchase. Brown received 2,158 shares coded as an acquisition grant for non-employee directors, which were fully vested when granted rather than bought on the open market.

What price per share is shown for Judy L. Brown’s Agilent (A) stock award?

The filing lists a value of $111.75 per share for the 2,158-share stock award. This figure typically reflects the grant-date fair market value used for compensation reporting rather than a cash purchase price paid by the director.

How many Agilent (A) shares does Judy L. Brown own after this Form 4 transaction?

After receiving the 2,158-share award, Brown directly owns 3,835 shares of Agilent common stock. The Form 4 explicitly reports this post-transaction total, giving investors a snapshot of her current direct equity stake in the company.

What does the footnote in Judy L. Brown’s Agilent (A) Form 4 explain?

The footnote explains that the shares were acquired from an Agilent common stock award for non-employee directors. It notes that these director shares are fully vested upon grant, clarifying that no additional vesting period applies to this stock award.